A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 181,662 shares of GILD stock, worth $16.8 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares
181,662
Previous 183,277 0.88%
Holding current value
$16.8 Million
Previous $12.6 Million 21.09%
% of portfolio
1.73%
Previous 1.5%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$66.59 - $83.99 $107,542 - $135,643
-1,615 Reduced 0.88%
181,662 $15.2 Million
Q2 2024

Jul 15, 2024

SELL
$63.15 - $72.88 $8.1 Million - $9.35 Million
-128,268 Reduced 41.17%
183,277 $12.6 Million
Q1 2024

Apr 15, 2024

BUY
$71.58 - $87.29 $1.02 Million - $1.24 Million
14,200 Added 4.78%
311,545 $22.8 Million
Q4 2023

Jan 24, 2024

SELL
$73.27 - $83.09 $476,914 - $540,832
-6,509 Reduced 2.14%
297,345 $24.1 Million
Q3 2023

Oct 12, 2023

BUY
$73.94 - $80.67 $230,914 - $251,932
3,123 Added 1.04%
303,854 $22.8 Million
Q2 2023

Jul 18, 2023

SELL
$76.01 - $86.7 $1.66 Million - $1.9 Million
-21,894 Reduced 6.79%
300,731 $23.2 Million
Q1 2023

Apr 13, 2023

BUY
$77.31 - $88.08 $444,764 - $506,724
5,753 Added 1.82%
322,625 $26.8 Million
Q4 2022

Jan 19, 2023

SELL
$62.32 - $89.47 $696,737 - $1 Million
-11,180 Reduced 3.41%
316,872 $0
Q3 2022

Oct 24, 2022

BUY
$59.54 - $68.01 $9.59 Million - $11 Million
161,043 Added 96.43%
328,052 $20.2 Million
Q2 2022

Jul 15, 2022

SELL
$57.72 - $65.01 $11.3 Million - $12.7 Million
-195,980 Reduced 53.99%
167,009 $10.3 Million
Q1 2022

Apr 22, 2022

BUY
$57.92 - $72.58 $1.96 Million - $2.45 Million
33,818 Added 10.27%
362,989 $21.6 Million
Q4 2021

Feb 10, 2022

SELL
$64.88 - $73.64 $1.46 Million - $1.65 Million
-22,445 Reduced 6.38%
329,171 $23.9 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $110,470 - $119,184
1,632 Added 0.47%
351,616 $24.6 Million
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $46,396 - $50,694
-731 Reduced 0.21%
349,984 $24.1 Million
Q1 2021

May 13, 2021

BUY
$60.0 - $68.46 $3.03 Million - $3.45 Million
50,430 Added 16.79%
350,715 $22.7 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $1.38 Million - $1.57 Million
24,354 Added 8.83%
300,285 $17.5 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $1.47 Million - $1.85 Million
23,702 Added 9.4%
275,931 $17.4 Million
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $2.93 Million - $3.41 Million
-40,551 Reduced 13.85%
252,229 $19.4 Million
Q1 2020

May 11, 2020

SELL
$62.63 - $80.22 $1.92 Million - $2.46 Million
-30,646 Reduced 9.48%
292,780 $21.9 Million
Q4 2019

Feb 11, 2020

BUY
$61.62 - $67.78 $1.96 Million - $2.15 Million
31,727 Added 10.88%
323,426 $21 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $817,630 - $902,520
13,080 Added 4.69%
291,699 $18.5 Million
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $1.13 Million - $1.27 Million
-18,257 Reduced 6.15%
278,619 $18.8 Million
Q1 2019

May 10, 2019

BUY
$62.53 - $70.05 $940,201 - $1.05 Million
15,036 Added 5.33%
296,876 $19.3 Million
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $208,499 - $272,076
3,444 Added 1.24%
281,840 $17.6 Million
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $646,794 - $716,120
9,074 Added 3.37%
278,396 $21.5 Million
Q2 2018

Aug 13, 2018

BUY
$64.88 - $75.68 $1.3 Million - $1.52 Million
20,046 Added 8.04%
269,322 $19.1 Million
Q1 2018

May 15, 2018

BUY
$72.84 - $88.8 $696,423 - $849,016
9,561 Added 3.99%
249,276 $18.8 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $1.15 Million - $1.35 Million
16,178 Added 7.24%
239,715 $17.2 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $1,946 - $2,307
27 Added 0.01%
223,537 $18.1 Million
Q2 2017

Aug 09, 2017

BUY
N/A
8,815 Added 4.11%
223,510 $15.8 Million
Q1 2017

May 10, 2017

BUY
N/A
16,632 Added 8.4%
214,695 $14.6 Million
Q4 2016

Feb 08, 2017

BUY
N/A
13,104 Added 7.08%
198,063 $14.2 Million
Q3 2016

Nov 07, 2016

BUY
N/A
29,174 Added 18.73%
184,959 $14.6 Million
Q2 2016

Aug 03, 2016

BUY
N/A
23,901 Added 18.12%
155,785 $13 Million
Q1 2016

May 05, 2016

BUY
N/A
10,643 Added 8.78%
131,884 $12.1 Million
Q4 2015

Feb 08, 2016

SELL
N/A
-50,678 Reduced 29.48%
121,241 $12.3 Million
Q3 2015

Nov 10, 2015

BUY
N/A
7,340 Added 4.46%
171,919 $16.9 Million
Q2 2015

Aug 07, 2015

SELL
N/A
-11,486 Reduced 6.52%
164,579 $19.3 Million
Q1 2015

May 08, 2015

BUY
N/A
119,166 Added 209.43%
176,065 $17.3 Million
Q4 2014

Feb 10, 2015

BUY
N/A
13,793 Added 32.0%
56,899 $5.36 Million
Q3 2014

Nov 06, 2014

BUY
N/A
250 Added 0.58%
43,106 $4.59 Million
Q2 2014

Aug 11, 2014

BUY
N/A
42,856
42,856 $3.55 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track David Katz's Portfolio

Track David Katz Portfolio

Follow David Katz (Matrix Asset Advisors Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.